SS
Steve Seedhouse Cantor Fitzgerald Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
28
Avg Return
Past Year
Past Year
4.5%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
88.9%
Neutral
11.1%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Maintained
| $26 |
292%
upside
| 1 | -9.8% |
0
%
| 15 Oct ‘25 4 days ago |
|
|
|
Overweight
Assumed
| $40 |
171%
upside
| 1 | +25% |
0
%
| 6 Oct ‘25 13 days ago |
|
|
|
Overweight
Initiated
| $7 |
139%
upside
| 1 | -0.68% |
0
%
| 2 Oct ‘25 17 days ago |
|
|
|
Market Perform
Downgraded
| – | – | 1 | +50% |
0
%
| 19 Sep ‘25 1 month ago |
|
|
|
Overweight
Reiterated
| $49 |
309%
upside
| 1 | +56% |
0
%
| 17 Sep ‘25 1 month ago |
|
|
|
Outperform
Reiterated
| $63 |
77%
upside
| 1 | +9.2% |
0
%
| 9 Sep ‘25 1 month ago |
|
|
|
Strong Buy
Maintained
| $147 |
249%
upside
| 1 | +26% |
0
%
| 13 Aug ‘25 2 months ago |
|
|
|
Strong Buy
Maintained
| $82 |
12%
upside
| 1 | +27% |
0
%
| 7 Aug ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $40 |
63%
upside
| 1 | +9.8% |
0
%
| 1 Aug ‘25 2 months ago |
|